Profile image
Story Views

Last Hour:
Last 24 Hours:

Sumitomo Dainippon Pharma Co Ltd – Product Pipeline Review – 2016 by Market Research Report Store

Wednesday, March 8, 2017 4:21
% of readers think this story is Fact. Add your two cents.

(Before It's News)

MarketResearchReportStore adds “Sumitomo Dainippon Pharma Co Ltd – Product Pipeline Review – 2016″ latest studies, published in March 2017. It is a professional and in-depth study on the current state.


For a sample of this report, please email at: 




‘Sumitomo Dainippon Pharma Co Ltd – Product Pipeline Review – 2016’, provides an overview of the Sumitomo Dainippon Pharma Co Ltd’s pharmaceutical research and development focus.


The report provides comprehensive information on the therapeutics under development by Sumitomo Dainippon Pharma Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.


The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.




- The report provides a snapshot of the pipeline therapeutic landscape of Sumitomo Dainippon Pharma Co Ltd

- The report provides overview of Sumitomo Dainippon Pharma Co Ltd including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Sumitomo Dainippon Pharma Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Sumitomo Dainippon Pharma Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects


Request Sample Copy, please email at: 


Table Of Contents

Sumitomo Dainippon Pharma Co Ltd – Pipeline Review 13

Pipeline Products by Stage of Development 13

Pipeline Products – Monotherapy 14

Pipeline Products – Partnered Products 15

Partnered Products/Combination Treatment Modalities 16

Pipeline Products – Out-Licensed Products 17

Out-Licensed Products/Combination Treatment Modalities 18

Sumitomo Dainippon Pharma Co Ltd – Pipeline Products Glance 19

Sumitomo Dainippon Pharma Co Ltd – Late Stage Pipeline Products 19

Pre-Registration Products/Combination Treatment Modalities 19

Phase III Products/Combination Treatment Modalities 20

Sumitomo Dainippon Pharma Co Ltd – Clinical Stage Pipeline Products 21

Phase II Products/Combination Treatment Modalities 21

Phase I Products/Combination Treatment Modalities 22

Sumitomo Dainippon Pharma Co Ltd – Early Stage Pipeline Products 23

Preclinical Products/Combination Treatment Modalities 23

Discovery Products/Combination Treatment Modalities 25

Sumitomo Dainippon Pharma Co Ltd – Drug Profiles 26

amrubicin hydrochloride – Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

blonanserin – Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

DSP-0011 – Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

DSP-1200 – Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

DSP-6952 – Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32


Browse Complete Report with TOC @


For report sample or more information, please feel free to contact us:

Shirley | Sales Director

Call: +00-1-626-3463946 - U.S   




About Us

Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.

Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.